Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79381 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Azithromycin N-Oxide
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H72N2O13Cor e Forma:White Crystalline PowderPeso molecular:764.50344Amlodipine Related Compound C (Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H18ClNO4Cor e Forma:Off-White Yellow Crystalline PowderPeso molecular:335.09244Allopurinol Related Compound A (3-Amino-4-carboxamidopyrazole Hemisulfate)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C4H6N4OH2O4SCor e Forma:Off-White Yellow PowderPeso molecular:350.31Bendamustine Related Compound H (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C32H41Cl3N6O4Cor e Forma:Off-White Yellow Orange SolidPeso molecular:678.22549Valacyclovir Related Compound F (2-hydroxyethyl valinate para-toluenesulfonate salt)
CAS:Non-aromatic amino-compounds with oxygen functionFórmula:C7H15NO3·C7H8O3SCor e Forma:White Off-White PowderPeso molecular:161.10519Rivaroxaban
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H18ClN3O5SCor e Forma:White PowderPeso molecular:435.06557Modafinil Sulfone
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C15H15NO3SCor e Forma:White Off-White PowderPeso molecular:289.07726Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H18N2O3SCor e Forma:PowderPeso molecular:270.10381Lorazepam Related Compound C (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C15H8Cl2N2OCor e Forma:White Crystalline SolidPeso molecular:302.00137Repaglinide Related Compound A ((S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate salt)
Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H26N2·C7H11NO5Cor e Forma:PowderPeso molecular:246.2096Dermatan Sulfate
CAS:Natural polymers & modified natural polymers, in primary forms, nesoiCor e Forma:White PowderPeso molecular:Average 46275Prednicarbate Related Compound A (1,2-Dihydroprednicarbate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C27H38O8Cor e Forma:White PowderPeso molecular:490.25667Ecamsule Related Compound G (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatFórmula:C18H19NaO5SCor e Forma:White PowderPeso molecular:370.4Acetylcysteine Related Compound C (2R,2'R)-3,3'-disulfanediylbis(2-acetamidopropanoic acid)
CAS:Organo-sulfur compounds, nesoiFórmula:C10H16N2O6S2Cor e Forma:White Crystalline PowderPeso molecular:324.04498Tigecycline Related Compound B ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x))
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C23H28N4O7·HClCor e Forma:Off-White PowderPeso molecular:472.1958Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C32H43NO6Cor e Forma:Light Grey Blue PowderPeso molecular:537.30904Acyclovir Related Compound G (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H15N5O5Cor e Forma:White Pale Yellow PowderPeso molecular:309.10732Methylprednisolone Hemisuccinate Related Compound B (11β,21-Dihydroxy-6α-methyl-3,20-dioxopregna-1,4-dien-17-yl hydrogen succinate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C26H34O8Cor e Forma:White SolidPeso molecular:474.22537Piroxicam Related Compound D (Methyl 2-[1,1-dioxido-3-oxobenzoisothiazol-2(3H)-yl]acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H9NO5SCor e Forma:White SolidPeso molecular:255.02014Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS:Compounds containing an unfused imidazole ring (whetherFórmula:C20H20Cl4N6Cor e Forma:White Off-White PowderPeso molecular:486.23Phenylbutyrate Related Compound B (3,4-dihydronaphthalen-1(2H)-one)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C10H10OCor e Forma:Yellow LiquidPeso molecular:146.19Adapalene Related Compound C (2-(adamant-1-yl)methoxybenzene)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C17H22OCor e Forma:PowderPeso molecular:242.16707Betamethasone Dipropionate Related Compound H (6α-Bromo-9-fluoro-11β-hydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C28H36BrFO7Cor e Forma:White PowderPeso molecular:582.16284Mesna Related Compound B (2,2'-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride)
Organo-sulfur compounds, nesoiFórmula:C4H8K2O6S4·NaClCor e Forma:White PowderPeso molecular:415.80641Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFórmula:C27H29BrN4O5Cor e Forma:Cream PowderPeso molecular:568.13213Formoterol Related Compound C (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:(C20H26N2O4)2·C4H4O4Cor e Forma:Off-White Light Brown SolidPeso molecular:832.38947Bosentan Related Compound E (4-(tert-butyl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C10H15NO2SCor e Forma:PowderPeso molecular:213.08235Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C13H18Cl2N2·ClHCor e Forma:White PowderPeso molecular:308.06138Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFórmula:C15H10ClN3O3Cor e Forma:Yellow-Orange PowderPeso molecular:315.04107Phenyltoloxamine Related Compound A (2-(2-Benzylphenoxy)ethylmethylamine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C16H19NO·HClCor e Forma:White Light Yellow PowderPeso molecular:241.14666Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C6H15NCor e Forma:Clear Colorless LiquidPeso molecular:101.12045Famciclovir Related Compound E (2-aminopurine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C5H5N5Cor e Forma:PowderPeso molecular:135.0545Diethyltoluamide Related Compound A (N,N-Diethyl-4-toluamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C12H17NOCor e Forma:White CrystalsPeso molecular:191.13101Urea
CAS:Urea, whether or not in aqueous solutionFórmula:CH4N2OCor e Forma:White Powder CrystalsPeso molecular:60.03236Phenylephrine Related Compound C (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C9H11NO2·HClCor e Forma:Yellow Yellow Green PowderPeso molecular:201.05566Dexketoprofen Tromethamine
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C16H14O3·C4H11NO3Cor e Forma:White PowderPeso molecular:375.16819Cyclizine Related Compound A (1-Methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H12N2Cor e Forma:Colorless Clear Pale Yellow LiquidPeso molecular:100.10005Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate
CAS:Sulfonamides, nesoiFórmula:C21H28N2O5SCor e Forma:White PowderPeso molecular:420.17189Zolmitriptan Related Compound F (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole})
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H53N7O4Cor e Forma:Orange PowderPeso molecular:671.4159Losartan Related Compound E (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1- yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C44H43Cl2KN12OCor e Forma:PowderPeso molecular:864.26969Progesterone Related Compound H (Pregna-4,6-diene-3,20-dione)
CAS:Estrogens and progestinsFórmula:C21H30O2Cor e Forma:Pale Yellow Off-White PowderPeso molecular:314.22458Febantel Related Compound B (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroFórmula:C15H14N2OSCor e Forma:Beige SolidPeso molecular:270.08268Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C6H6N6OCor e Forma:White Off-White Crystalline PowderPeso molecular:178.06031Mafenide Related Compound A (4-Formylbenzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C7H7NO3SCor e Forma:White PowderPeso molecular:185.2Hydroxyzine Related Compound A (1-[(4-Chlorophenyl)phenylmethyl]piperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C17H19ClN2Cor e Forma:PowderPeso molecular:286.123684-Hydrazinylbenzenesulfonamide Hydrochloride
CAS:Sulfonamides, nesoiFórmula:C6H9N3O2S·HClCor e Forma:Light Yellow Beige Crystalline PowderPeso molecular:223.01823Paclitaxel Related Compound B (10-deacetyl-7-epipaclitaxel)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C45H49O13NCor e Forma:White Off-White PowderPeso molecular:811.32039Brinzolamide Related Compound A ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer))
CAS:Sulfonamides, nesoiFórmula:C12H21N3O5S3Cor e Forma:White Off-White PowderPeso molecular:383.06433Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C11H15NO4Cor e Forma:White PowderPeso molecular:225.10011Pimobendan Related Compound B (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C19H20N4O3Cor e Forma:White Off-White PowderPeso molecular:352.15354Bisacodyl Related Compound C (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C20H17NO3Cor e Forma:SolidPeso molecular:319.12084Guanylmelamine Dinitrate (1-(4,6-diamino-1,3,5-triazin-2-yl)guanidine, nitrate)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C4H8N8·2HNO3Cor e Forma:Off-White SolidPeso molecular:168.08719Felbamate Related Compound A (3-Hydroxy-2-phenylpropyl carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C10H13NO3Cor e Forma:White Crystalline PowderPeso molecular:195.08954Cyproheptadine Related Compound C (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol)
CAS:Cyclanic, cyclenic or cycloterpenic ketones without other oxygen function not elsewhere specified or includedFórmula:C21H23NOCor e Forma:Off-White PowderPeso molecular:305.17796Triclocarban Related Compound A (1,3-Bis(4-chlorophenyl)urea)
CAS:Ureines and their derivatives; salts thereofFórmula:C13H10Cl2N2OCor e Forma:White Off-White PowderPeso molecular:280.01702Fosinopril Related Compound E ((4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C30H39NNaO7PCor e Forma:White PowderPeso molecular:579.23618Oxymetholone Related Compound B (17β-Hydroxy-1-hydroxymethylene-17α-methyl-5α-androstan-3-one)
CAS:Ketone-alcohols and ketone-aldehydes, nesoiFórmula:C21H32O3Cor e Forma:Off-White Light Yellow SolidPeso molecular:332.23514Palonosetron Related Compound A ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)
CAS:Lactams not elsewhere specified or includedFórmula:C19H24N2O2Cor e Forma:White SolidPeso molecular:312.18378Meloxicam Related Compound C (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H15NO5SCor e Forma:White Light Pink Solid PowderPeso molecular:297.06709Valproic Acid Related Compound A (2-allylpent-4-enoic acid)
CAS:Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFórmula:C8H12O2Cor e Forma:Clear LiquidPeso molecular:140.08373Hexyl Methanesulfonate
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFórmula:C7H16O3SCor e Forma:Clear Yellow LiquidPeso molecular:180.08202Xylometazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-2,6-dimethylphenyl]acetamide)
CAS:Sulfonamides used as drugsFórmula:C16H26N2OCor e Forma:Off-White SolidPeso molecular:262.204512,3-Dimethylaniline
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C8H11NCor e Forma:Clear Yellow Amber Red Brown LiquidPeso molecular:121.08915Baclofen Related Compound A (4-(4-Chlorophenyl)-2-pyrrolidinone)
CAS:Lactams, nesoiFórmula:C10H10ClNOCor e Forma:White CrystalsPeso molecular:195.04509Theophylline Related Compound D (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate)
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C6H10N4O·HCl·H2OCor e Forma:Off-White Light Brown PowderPeso molecular:208.0727Epoprostenol Related Compound A (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H34O6Cor e Forma:White PowderPeso molecular:370.23554Timolol Related Compound E ((S,Z)-4-({1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-yl}oxy)-4-oxobut-2-enoic acid maleate salt (1:1)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H26N4O6S·C4H4O4Cor e Forma:Off-White PowderPeso molecular:414.15731Pergolide Sulfoxide ((8β)-8-[(Methylsulfinyl)methyl]-6-propyl-D-ergoline)
CAS:Alkaloids of rye ergot and their derivatives; salts thereof, nesoiFórmula:C19H26N2OSCor e Forma:PowderPeso molecular:330.17658Celecoxib Related Compound D ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C15H17N3O2SCor e Forma:Pale Yellow Off-White SolidPeso molecular:303.10415Triclocarban Related Compound C (1,3-Bis(3,4-dichlorophenyl)urea)
CAS:Ureines and their derivatives; salts thereofFórmula:C13H8Cl4N2OCor e Forma:White Off-White PowderPeso molecular:347.93907Carprofen Related Compound A (Carbazole)
CAS:CarbazoleFórmula:C12H9NCor e Forma:Beige PowderPeso molecular:167.0735D-Valganciclovir (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H22N6O5·HCICor e Forma:Off-White PowderPeso molecular:494.07746Citalopram Related Compound G (3-[5-Chloro-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine hydrobromide)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C19H21ClFNO·HBrCor e Forma:White PowderPeso molecular:333.12957Galantamine Hydrobromide Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderSalicylic Acid Related Compound A (4-hydroxybenzoic acid)
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc nesoiFórmula:C7H6O3Cor e Forma:White PowderPeso molecular:138.031691,2-Dinitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFórmula:C3H6N2O7Cor e Forma:Clear Colorless LiquidPeso molecular:182.0175Dipivefrin Related Compound E (4-[(Methylamino)acetyl]-1,2-phenylene dipivalate hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C19H27NO5Cor e Forma:SolidPeso molecular:349.18892Rivastigmine Related Compound A ((+)-Di-(p-toluoyl)-D-tartaric acid)
CAS:Salts and esters of tartaric acidFórmula:C20H18O8Cor e Forma:PowderPeso molecular:386.10017Azelastine Related Compound E (3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one)
Lactones nesoiFórmula:C15H9ClO2Cor e Forma:PowderPeso molecular:256.02911Pramipexole Related Compound A ((S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C7H11N3SCor e Forma:Off-White Light Brown Grey PowderPeso molecular:169.06737Uridine (1-β-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C9H12N2O6Cor e Forma:PowderPeso molecular:244.06954Alprazolam Related Compound A (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H15ClN4OCor e Forma:White PowderPeso molecular:326.09344Azacitidine Related Compound A (4-Amino-1,3,5-triazin-2(1H)-one)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C3H4N4OCor e Forma:White Off-White PowderPeso molecular:112.03851Terbinafine Related Compound D ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C22H27N·HClCor e Forma:White PowderPeso molecular:305.21435Cefotaxime Related Compound E ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H13N5O5S2Cor e Forma:Off-White Light Yellow PowderPeso molecular:395.035812-Mononitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFórmula:C3H7NO5Cor e Forma:Clear Colorless LiquidPeso molecular:137.03242Nicotine Related Compound A (1,2,3,6-tetrahydro-2,3'-bipyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H12N2Cor e Forma:Pale Yellow Light Brown LiquidPeso molecular:160.10005Amlodipine Related Compound D (3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxoisoindolin-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C28H27ClN2O7Cor e Forma:Off-White PowderPeso molecular:538.15068Bisoprolol Related Compound E (3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol))
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C33H53NO8Cor e Forma:Colorless Gummy LiquidPeso molecular:591.37712Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C20H25N5O2Cor e Forma:White Brown PowderPeso molecular:367.20083Carglumic Acid Related Compound C ((S)-2-[(S)-4-Carboxy-2-ureidobutanamido]pentanedioic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C11H17N3O8Cor e Forma:Off-White PowderPeso molecular:319.10156Formoterol Related Compound A (2-Amino-4-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C18H24N2O3Cor e Forma:Off-White Grey SolidPeso molecular:316.17869Nicotine Related Compound C ((S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H12N2OCor e Forma:White Off-White PowderPeso molecular:176.09496Clobetasol Propionate Related Compound A (9α-Fluoro-11β-hydroxy-16β-methyl 3-oxo-androsta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one])
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C25H30ClFO4Cor e Forma:White PowderPeso molecular:448.18167Doxazosin Related Compound E (2,4-dichloro-6,7-dimethoxyquinazoline)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H8Cl2N2O2Cor e Forma:Light Orange Light Yellow PowderPeso molecular:257.99628γ-Aminobutyric Acid
CAS:Amino-acids and their esters other than those containing more than one kind of oxygen function, excluding aromatic amino-acids, nesoiFórmula:C4H9NO2Cor e Forma:White Crystalline PowderPeso molecular:103.06333Benzalkonium Chloride (5 mL of approx. 4% aqueous solution)
CAS:<p>Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale</p>Cor e Forma:Clear Colorless LiquidTorsemide Related Compound C (N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)
CAS:Sulfonamides, excluding drugsFórmula:C15H18N4O3SCor e Forma:White Off-White PowderPeso molecular:334.10996Famciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H17N5O3Cor e Forma:Off-White PowderPeso molecular:279.13314Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C23H26N2O5Cor e Forma:White PowderPeso molecular:410.18417Racemic Tiagabine Hydrochloride Mixture ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFamciclovir Related Compound A (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol] hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H15N5O2·HClCor e Forma:Cream Off-White SolidPeso molecular:237.12257Vardenafil Related Compound E (2-[2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)
CAS:Sulfonamides, nesoiFórmula:C21H28N6O4SCor e Forma:White PowderPeso molecular:460.18927Articaine Related Compound E (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H20N2O3SCor e Forma:White PowderPeso molecular:284.11946Iopromide Related Compound A (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C15H20I3N3O6Cor e Forma:White Crystalline PowderPeso molecular:718.84863Gatifloxacin Related Compound E (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C19H22FN3O4·HClCor e Forma:SolidPeso molecular:411.13611Amoxicillin Related Compound J (Mixture of amoxicillin and amoxicillin related compound J (amoxicillin open ring dimer))
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White Yellow PowderEconazole Related Compound A (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C11H10Cl2N2OCor e Forma:White Beige PowderPeso molecular:256.01702Chloroquine Related Compound A (4,7-dichloroquinoline)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C9H5Cl2NCor e Forma:Off-White Brownish Yellow CrystalsPeso molecular:196.9799Ursodiol Related Compound H (3β, 7β-Dihydroxy-5β-cholan-24-oic acid)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C24H40O4Cor e Forma:White Fine PowderPeso molecular:392.29266Dexmedetomidine Related Compound B (4-[1-(2,3-Dimethylphenyl)vinyl]-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C13H14N2Cor e Forma:White Off-White PowderPeso molecular:198.1157Proguanil Related Compound E (1-(4-chlorophenyl)-3-cyanoguanidine)
CAS:Nitrile function compounds, not elsewhere specified orFórmula:C8H7ClN4Cor e Forma:White Off-White PowderPeso molecular:194.03592Nebivolol Related Compound E (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride)
Aromatic pesticides with oxygen heteroFórmula:C22H26FNO4·HClCor e Forma:PowderPeso molecular:423.16126Lacosamide S-Enantiomer ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C13H18N2O3Cor e Forma:White PowderPeso molecular:250.13174Terbinafine Related Compound C ((2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C21H25N·HClCor e Forma:White Off-White PowderPeso molecular:327.17538Foscarnet Related Compound D (O,O-diethyl ethoxycarbonylphosphonate)
CAS:Non-halogenated organo-phosphorous derivatives, nesoiFórmula:C7H15O5PCor e Forma:Colorless Yellow Clear LiquidPeso molecular:210.06571Fluticasone Propionate Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:PowderRepaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C27H36N2O4Cor e Forma:PowderPeso molecular:452.26751Isoflurane Related Compound B (2,2,2-Trifluoroethyl difluoromethyl ether)
CAS:Ethers of monohydric alcohols, nesoiFórmula:C3H3F5OCor e Forma:Colorless Clear LiquidPeso molecular:150.01041Tranexamic Acid Related Compound C ((RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid hydrochloride)
CAS:Amino-acids and their esters other than those containing more than one kind of oxygen function, excluding aromatic amino-acids, nesoiFórmula:C8H13NO2·HClCor e Forma:White Off-White PowderPeso molecular:191.07131Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H20ClN3O6SCor e Forma:Pale Yellow SolidPeso molecular:453.07613Metaxalone Related Compound B (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C11H17NO2Cor e Forma:White PowderPeso molecular:195.12593Propafenone Related Compound B (RS,E)-1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C21H25NO3Cor e Forma:Off-White PowderPeso molecular:339.18344Nebivolol Related Compound C ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman)
CAS:Aromatic pesticides with oxygen heteroFórmula:C11H11FO2Cor e Forma:Liquid Low-Melting SolidPeso molecular:194.07431Irinotecan Related Compound B ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C22H20N2O5Cor e Forma:Yellow Off-White PowderPeso molecular:392.13722Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H17Cl2NO2SCor e Forma:White Off-White PowderPeso molecular:357.03571Procarbazine Related Compound A (4-Formyl-N-isopropylbenzamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H13NO2Cor e Forma:White Yellow SolidPeso molecular:191.09463Citalopram Related Compound F (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C18H21N·ClHCor e Forma:White Crystalline PowderPeso molecular:287.14408Brimonidine Related Compound A (5-Bromoquinoxalin-6-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C8H6BrN3Cor e Forma:Yellow Crystalline PowderPeso molecular:222.97451Cyclosporin D
CAS:Lactams, nesoiFórmula:C63H113N11O12Cor e Forma:White Off-White SolidPeso molecular:1215.85702Lomustine Related Compound B (1-(2-Chloroethyl)-3-cyclohexylurea)
CAS:Compounds with other nitrogen function, nesoiFórmula:C9H17ClN2OCor e Forma:SolidPeso molecular:204.10294Amoxicillin Related Compound H ((R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C13H17NO4Cor e Forma:Off-White PowderPeso molecular:251.11576Decitabine Related Compound E (4-Amino-1-(2-deoxy-α-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C8H12N4O4Cor e Forma:White PowderPeso molecular:228.08585Tetrahydrozoline Related Compound E (N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C13H18N2OCor e Forma:White SolidPeso molecular:218.14191Zileuton Related Compound C (1-(Benzo[b]thiophen-2-yl)ethan-1-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H8OSCor e Forma:Off-White Crystalline PowderPeso molecular:176.02959Dronedarone Related Compound D ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone)
CAS:Aromatic pesticides with oxygen heteroFórmula:C19H17NO5Cor e Forma:SolidPeso molecular:339.11067Nebivolol Stereoisomer Mixture
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiCor e Forma:White PowderTacrolimus 8-propyl analog (See USP Certificate for full Chemical Name)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C44H71NO12Cor e Forma:White PowderPeso molecular:805.49763Lamotrigine Related Compound D (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C16H9Cl4N5OCor e Forma:White PowderPeso molecular:426.95612Ketorolac Related Compound B (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H13NO2Cor e Forma:Yellow SolidPeso molecular:227.09463Latanoprost Related Compound D (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5-bis(triethylsilyloxy)cyclopentyl}hept-5-enoate)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C44H82O5Si3Cor e Forma:Yellow LiquidPeso molecular:774.54701Proguanil Related Compound F (1-(3,4-Dichlorophenyl)-5-isopropylbiguanide hydrochloride)
CAS:Aromatic imines and their derivatives, salts thereofFórmula:C11H15Cl2N5·HCICor e Forma:White Crystalline PowderPeso molecular:426.98275Methyldopa Related Compound C ((S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid hydrochloride monohydrate)
Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C12H17NO4·HCl·H2OCor e Forma:PowderPeso molecular:293.103Prednicarbate Related Compound B (Prednisolone-17-ethylcarbonate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C24H3207Cor e Forma:White Crystalline PowderPeso molecular:3520.09488Tiotropium Related Compound C ((1R,3s,5S)-3-[2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy]-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium bromide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H22BrNO3S2Cor e Forma:White Yellow PowderPeso molecular:455.02245Dicyclomine Related Compound A ([1,1'-Bi(cyclohexane)]-1-carboxylic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFórmula:C13H22O2Cor e Forma:White Crystalline PowderPeso molecular:210.16198Methylprednisolone Hemisuccinate Related Compound D (11β,17-Dihydroxy-6α-methyl-3,20-dioxopregna-4-en-21-yl hydrogen succinate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C26H36O8Cor e Forma:White Off-White SolidPeso molecular:476.24102Ramipril Related Compound B ((2S,3aS,6aS)-1-{[(S)-1-Methoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C24H34N2O5Cor e Forma:White PowderPeso molecular:430.24677Iopamidol Related Compound B (N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxyacetamido)-2,4,6-triiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C16H20I3N3O8Cor e Forma:White PowderPeso molecular:762.83846Tioconazole Related Compound C (1-[2,4-Dichloro-β-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H12BrCl3N2OS·HClCor e Forma:Off-White PowderPeso molecular:463.89193Nevirapine Related Compound C (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one)
Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C15H16N4OCor e Forma:PowderPeso molecular:268.13241Proguanil Related Compound A (1-cyano-3-isopropylguanidine)
CAS:Nitrile function compounds, not elsewhere specified orFórmula:C5H10N4Cor e Forma:White Crystalline PowderPeso molecular:126.09055Nabumetone Related Compound A (1-(6-methoxy-2-naphthyl)-but-1-en-3-one)
CAS:Ketone-phenols and ketones with other oxygen functionFórmula:C15H14O2Cor e Forma:Light Yellow PowderPeso molecular:226.09938Galantamine Hydrobromide Racemic
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C17H21NO3·HBrCor e Forma:White Crystalline PowderPeso molecular:287.15214Bosentan Related Compound A (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C25H24ClN5O4SCor e Forma:White PowderPeso molecular:525.12375Darifenacin Related Compound G (5-(2-Bromoethyl)-2,3-dihydrobenzofuran)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C10H11BrOCor e Forma:White Pale Yellow PowderPeso molecular:225.99933Cidofovir Enantiomer (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C8H14N3O6PCor e Forma:White Off-White PowderPeso molecular:279.06202Flavoxate Related Compound A (3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C17H12O4Cor e Forma:White Off-White PowderPeso molecular:280.07356Propofol Related Compound C (2,6-diisopropylphenyl isopropyl ether)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C15H24OCor e Forma:LiquidPeso molecular:220.18272Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFórmula:C23H37N7O5SCor e Forma:Off-White PowderPeso molecular:523.25769Imiquimod Related Compound B (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H15N3OCor e Forma:Yellow PowderPeso molecular:241.12151Metformin Related Compound C (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C5H10N6Cor e Forma:White Off-White PowderPeso molecular:154.09669Buspirone Related Compound K (8-azaspiro[4.5]decane-7,9-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFórmula:C9H13NO2Cor e Forma:White PowderPeso molecular:167.09463Moxifloxacin Related Compound C (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFórmula:C22H26FN3O4·HCl·H2OCor e Forma:SolidPeso molecular:415.19073Glycopyrrolate Related Compound A (5-Nitrobenzene-1,3-dicarboxylic acid)
CAS:Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc, nesoiFórmula:C8H5NO6Cor e Forma:White Off-White Yellow PowderPeso molecular:211.01169Tetrabenazine Related Compound C ((3RS,11bRS)-3-Butyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C19H27NO3Cor e Forma:Off-White PowderPeso molecular:317.19909Roflumilast Related Compound C (3,5-Dichloropyridin-4-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C5H4Cl2N2Cor e Forma:White Yellow PowderPeso molecular:161.97515Methylprednisolone Related Compound C (11β-Hydroxy-6α-methylandrosta-1,4-diene-3,17-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C20H26O3Cor e Forma:PowderPeso molecular:314.18819Norfloxacin Related Compound H (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C19H22FN3O5Cor e Forma:Off-White PowderPeso molecular:391.15435Topotecan Related Compound C ((S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C20H16N2O4Cor e Forma:PowderPeso molecular:348.11101Rabeprazole Related Compound B (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C18H21N3O4SCor e Forma:White PowderPeso molecular:375.12528Phentermine Related Compound A (N-(2-Methyl-1-phenylpropan-2-yl)formamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H15NOCor e Forma:White Off-White PowderPeso molecular:177.11536Propofol Related Compound A (3,3',5,5'-Tetraisopropylbiphenyl-4,4'-diol)
CAS:Polyphenols, nesoiFórmula:C24H34O2Cor e Forma:Yellow PowderPeso molecular:354.25588Cefprozil Related Compound D ((6R,7R)-7-amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H12N2O3SCor e Forma:White Off-White PowderPeso molecular:240.05686Cefaclor δ-3 Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClN3O4SCor e Forma:Off-White Tan PowderPeso molecular:367.03935Antazoline Related Compound A (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H21N3OCor e Forma:SolidPeso molecular:283.16846Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:Sulfonamides, nesoiFórmula:C19H27N3O6S2Cor e Forma:Off-White PowderPeso molecular:457.13413Perphenazine Related Compound B (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C21H27N3OSCor e Forma:Off-White PowderPeso molecular:369.18748Granisetron Related Compound A (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H24N4OCor e Forma:White Off-White PowderPeso molecular:312.19501Carisoprodol Related Compound A (2-hydroxymethyl-2-methylpentyl carbamate)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C8H17NO3Cor e Forma:White PowderPeso molecular:175.12084Daunorubicinone ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione)
CAS:Ketone-phenols and ketones with other oxygen functionFórmula:C21H18O8Cor e Forma:Orange Red PowderPeso molecular:398.10017Atenolol Related Compound C (2-[4-(Oxiran-2-ylmethoxy)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H13NO3Cor e Forma:White SolidPeso molecular:207.08954Aprepitant Related Compound B (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H21F7N4O3Cor e Forma:White Off-White Crystalline PowderPeso molecular:534.15019Glipizide Related Compound B (6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide)
CAS:Sulfonamides, nesoiFórmula:C14H16N4O3SCor e Forma:White PowderPeso molecular:320.09431Methimazole Related Compound C (1-Methyl-2-(methylthio)-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C5H8N2SCor e Forma:Clear Pale Yellow LiquidPeso molecular:128.04082Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C20H21F2N3O3Cor e Forma:White Off-White PowderPeso molecular:389.1551Clarithromycin Impurity Q (Clarithromycin N-oxide)
CAS:Lactones nesoiFórmula:C38H69NO14Cor e Forma:White PowderPeso molecular:763.47181Isomalathion (Diethyl 2-{[methoxy(methylthio)phosphoryl]thio}succinate)
CAS:Organo-sulfur compounds, nesoiFórmula:C10H19O6PS2Cor e Forma:Colorless Clear LiquidPeso molecular:330.03607Estazolam Related Compound A (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C16H11Cl2N3OCor e Forma:Light Yellow Off-White White Crystalline PowderPeso molecular:331.02792Imiquimod Related Compound C (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H14ClN3Cor e Forma:White Crystalline PowderPeso molecular:259.08763N-Nitroso Diclofenac (2-(2-((2,6-dichlorophenyl) (nitroso)amino)phenyl)acetic acid)
CAS:Compounds with other nitrogen function, nesoiFórmula:C14H10Cl2N2O3Cor e Forma:Off-White PowderPeso molecular:324.00685Trazodone Related Compound D (2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C19H22BrN5O·HClCor e Forma:White Crystalline PowderPeso molecular:415.10077Ethacrynic Acid Related Compound C ({4-[2-(4-(Carboxymethoxy)-2,3-dichlorobenzoyl)-2,5-diethyl-3,4-dihydro-2H-pyran-6-yl]-2,3-dichlorophenoxy}acetic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C26H24Cl4O8Cor e Forma:Off-White PowderPeso molecular:604.02253Succinylmonocholine Chloride
CAS:Quaternary ammonium salts and hydroxides, whether or not chemically defined, nesoiFórmula:C9H18ClNO4Cor e Forma:White PowderPeso molecular:239.09244Rivastigmine Related Compound D (3-Acetylphenyl ethyl(methyl)carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C12H15NO3Cor e Forma:White PowderPeso molecular:221.105196-Ketonorethindrone Acetate (3,6-Dioxo-19-nor-17α pregn-4-en-20-yn-17-yl acetate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFórmula:C22H26O4Cor e Forma:Light Yellow PowderPeso molecular:354.18311Raloxifene Related Compound C (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C28H27NO5SCor e Forma:Yellow PowderPeso molecular:489.16099Miconazole Related Compound F (1-{2-[(3,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C18H14Cl4N2OCor e Forma:PowderPeso molecular:413.98602Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C15H14N2O3SCor e Forma:White Fine PowderPeso molecular:302.07251Orphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride)
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFórmula:C17H21NO·ClHCor e Forma:White Off-White PowderPeso molecular:291.13899
![Acyclovir Related Compound G (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl ac…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1012087.webp&w=3840&q=75)
![Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}ami…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1600868.webp&w=3840&q=75)
![Propafenone Related Compound B (RS,E)-1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1570326.webp&w=3840&q=75)
![Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1140597.webp&w=3840&q=75)
![Lamotrigine Related Compound D (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichloro…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1356790.webp&w=3840&q=75)
![Topotecan Related Compound C ((S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1672280.webp&w=3840&q=75)
![Perphenazine Related Compound B (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1511021.webp&w=3840&q=75)
![Raloxifene Related Compound C (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phe…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1598234.webp&w=3840&q=75)
![Orphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1479031.webp&w=3840&q=75)